Sponsored by
Associated Press
  •  

Opening Glance: Biotechnology

By Associated Press May 20, 2008 Comments (0)

0 Recommendations

Shares of large-cap biotechnology companies opened slightly higher Tuesday, bucking a downturn in the broader market as oil prices spiked and a government report pointed to rising wholesale inflation.

The Dow Jones Industrial average fell 145 points shortly after the opening bell.

Here's how several key biotechnology stocks performed early Tuesday:

Celgene Corp., up a penny to $59.98

Amgen Inc., up 51 cents to $42.85.

Biogen Idec Inc., up 92 cents to $63.67.

Genentech Inc., down 37 cents to $69.83.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 648492, ~/articles/articlehandler.aspx, 7/23/2008 5:48:25 PM, No ticker

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

No, thanks

Related Tickers

Amgen, Inc.

AMGN Down! $53.92 -0.68 (-1.25%) 4:00 PM
CAPS Rating:
1630 Outperforms
141 Underperforms
Rate This Stock

Major Indices

S&P 5001,282.11+0.40%
DJIA11,632.38+0.26%
RSL 2K719.19+0.33%
NASD2,325.88+0.95%
Updated: 4:02:47 PM
Sponsored by:

The Motley Poll

What company will see the next Bear Stearns-style implosion?

Sponsored by: